SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-20-000010
Filing Date
2020-04-17
Accepted
2020-04-16 20:32:53
Documents
1
Period of Report
2020-04-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20200414x8k.htm 8-K 51783
  Complete submission text file 0001358403-20-000010.txt   53150
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 20797509
SIC: 2834 Pharmaceutical Preparations